Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
Public ClinicalTrials.gov record NCT01511198. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
NNC 90-1170 Dose-response, Efficacy and Safety: A 12-week Randomized, Multicenter, Doubleblind, Double-dummy, Parallel-group Study of Metformin and Five Doses of NNC 90-1170 in Previously-treated OHA Monotherapy Obese Subjects With Type 2 Diabetes
Study identification
- NCT ID
- NCT01511198
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Enrollment
- 223 participants
Conditions and interventions
Conditions
Interventions
- liraglutide Drug
- metformin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2001
- Primary completion
- Sep 30, 2001
- Completion
- Sep 30, 2001
- Last update posted
- Jan 25, 2017
2001
United States locations
- U.S. sites
- 39
- U.S. states
- 19
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Vestavia Hills | Alabama | 35209 | — |
| Novo Nordisk Investigational Site | Tucson | Arizona | 85719 | — |
| Novo Nordisk Investigational Site | Carlisle | Arkansas | 72024 | — |
| Novo Nordisk Investigational Site | Jonesboro | Arkansas | 72401 | — |
| Novo Nordisk Investigational Site | Alhambra | California | 91801 | — |
| Novo Nordisk Investigational Site | Mission Viejo | California | 92691 | — |
| Novo Nordisk Investigational Site | Walnut Creek | California | 94598 | — |
| Novo Nordisk Investigational Site | Trumbull | Connecticut | 06611 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32216 | — |
| Novo Nordisk Investigational Site | Melbourne | Florida | 32901 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33156 | — |
| Novo Nordisk Investigational Site | Ocala | Florida | 34471 | — |
| Novo Nordisk Investigational Site | Pembroke Pines | Florida | 33024 | — |
| Novo Nordisk Investigational Site | St. Petersburg | Florida | 33702 | — |
| Novo Nordisk Investigational Site | Titusville | Florida | 32796 | — |
| Novo Nordisk Investigational Site | West Palm Beach | Florida | 33401 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60607 | — |
| Novo Nordisk Investigational Site | Springfield | Illinois | 62711 | — |
| Novo Nordisk Investigational Site | Worcester | Massachusetts | 01605 | — |
| Novo Nordisk Investigational Site | Duluth | Minnesota | 55805 | — |
| Novo Nordisk Investigational Site | St Louis | Missouri | 63117 | — |
| Novo Nordisk Investigational Site | St Louis | Missouri | 63141 | — |
| Novo Nordisk Investigational Site | North Plainfield | New Jersey | 07060 | — |
| Novo Nordisk Investigational Site | Charlotte | North Carolina | 28277 | — |
| Novo Nordisk Investigational Site | Durham | North Carolina | 27710 | — |
| Novo Nordisk Investigational Site | Oklahoma City | Oklahoma | 73104 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37404 | — |
| Novo Nordisk Investigational Site | Corpus Christi | Texas | 78404 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75230 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75246 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78209 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78229 | — |
| Novo Nordisk Investigational Site | Salt Lake City | Utah | 84132 | — |
| Novo Nordisk Investigational Site | Richmond | Virginia | 23294 | — |
| Novo Nordisk Investigational Site | Edmonds | Washington | 98026-7610 | — |
| Novo Nordisk Investigational Site | Edmonds | Washington | 98026 | — |
| Novo Nordisk Investigational Site | Renton | Washington | 98057 | — |
| Novo Nordisk Investigational Site | Tacoma | Washington | 98405 | — |
| Novo Nordisk Investigational Site | Charleston | West Virginia | 25301 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01511198, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 25, 2017 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01511198 live on ClinicalTrials.gov.